CLINICAL_TRIALS
trial_result
· 2013-03-14
Clinical Trial Update: Exenatide Versus Glimepiride in Patients With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 head-to-head trial comparing exenatide with glimepiride in adults with type 2 diabetes has completed, with results posted in March 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-03-14